PharmaHub · Pharma Value Chain · Latin America

Argentina Neurology Devices Market Size, Share Outlook, Growth Analysis Report and Forecast Trends 2026-2030

The Argentina neurology devices market is valued at approximately $120 million in 2025 and is projected to grow at a steady 6.5% annual rate through 2030, reflecting expanding demand for neurological care across the country. This market encompasses medical devices used to diagnose, treat, and monitor conditions such as stroke, epilepsy, Parkinson's disease, and traumatic brain injuries. Growth is primarily driven by an aging population, rising incidence of neurological disorders, and significant regulatory improvements under Argentina's ANMAT that have substantially increased medical device registrations in recent years.

Market size · 2025
$120 million
CAGR · 2025–2030
6.5%
Forecast · 2030
$164 million
Basis
Claight Analysis
Market size (USD)
Base year 2025
Official data · Claight AnalysisForecast
Market size and forecast are Claight Analysis, informed by public research.
Forecast
2021
2022
2023
2024
2025
2026
2027
2028
2029
2030
2025 base: $120M2030 est: $164M
Read the full Argentina Neurology Devices Market report →

Market Overview

The market covers a range of devices including cerebrospinal fluid management systems, neurovascular interventions, neurostimulation equipment, and neurosurgical instruments used in hospitals and specialty clinics throughout Argentina. As one of the more developed medical device markets in Latin America, Argentina's neurology segment operates within a mixed public-private healthcare system where both sectors generate demand for diagnostic and therapeutic devices. The market functions within a regulatory environment overseen by ANMAT, the National Administration of Drugs, Foods, and Medical Devices, which has shown significant activity in approving new medical technologies in recent years.

  • Market valued at approximately $120 million in 2025 with steady expansion expected through 2030
  • Covers device categories including cerebrospinal fluid management, neurovascular, and neurostimulation equipment
  • Operates within Argentina's mixed public-private healthcare system overseen by ANMAT regulators

Growth Drivers

A primary growth driver is the increasing burden of neurological diseases, particularly stroke and neurodegenerative conditions, linked to demographic shifts toward an older population requiring more specialized medical interventions. Regulatory reforms under ANMAT have streamlined medical device registration processes significantly, with the number of registered medical devices in Argentina having increased dramatically since 2017, improving patient access to modern neurological technologies. Additionally, ongoing efforts to modernize healthcare infrastructure and expand specialized neurology services across major urban centers create sustained demand for advanced diagnostic and surgical equipment.

  • Rising prevalence of neurological disorders driven by aging population demographics
  • ANMAT registration improvements have dramatically expanded device access and approvals since 2017
  • Healthcare infrastructure modernization and expanded neurology services in urban centers
Want a deeper cut on Argentina Neurology Devices Market? We build bespoke studies on request.
Connect to an analyst →

Segmentation and Regional Analysis

The market is organized by device type, with cerebrospinal fluid management systems forming a substantial segment alongside neurovascular devices, neurostimulation equipment, and neurosurgical navigation systems. Geographic demand concentrates heavily in Buenos Aires and the surrounding province, which host the majority of tertiary care hospitals and specialized neurology centers, though secondary cities like Córdoba and Rosario show growing adoption as regional healthcare networks expand. The market serves both public hospital systems that account for the largest share of procedures and private healthcare institutions that typically adopt newer technologies at a faster pace.

  • Device categories include cerebrospinal fluid management, neurovascular, neurostimulation, and neurosurgical instruments
  • Demand concentrated in Buenos Aires metropolitan area with growing adoption in Córdoba, Rosario, and other regional centers
  • Public hospitals represent the largest volume segment while private institutions drive technology adoption

Trends and Outlook

What are the recent trends and outlook?

Minimally invasive neurosurgical techniques are driving demand for advanced navigation systems and specialized instruments that reduce procedure times and improve patient outcomes, particularly in urban medical centers with modern infrastructure. The market is expected to maintain its 6.5% annual growth trajectory toward 2030, supported by continued regulatory streamlining, gradual healthcare investment, and introduction of next-generation neurostimulation and neurovascular technologies. However, economic volatility and import dependencies present ongoing challenges that could affect the pace of technology adoption and device availability in the Argentine healthcare market.

  • Minimally invasive procedures and advanced navigation systems gaining adoption in major hospitals
  • Steady 6.5% annual growth expected through 2030 driven by regulatory improvements and technology introduction
  • Economic factors and import dependencies may moderate adoption pace despite underlying demand growth
Talk to a Claight analyst
Do you want to research Argentina Neurology Devices Market?

Get in touch and our analysts will be happy to help with custom market sizing, deeper segmentation, supplier detail or a bespoke study built for you.

Connect to an analyst →

Market size and forecast are Claight Analysis, informed by public research and industry data. Historical years before 2025 and all forecast years are Claight estimates at the stated CAGR. Retrieved 2026.